Finance

Beta
Lists
L020:FRA
Britannia Life Sciences Inc
€0.032
+3.28%
(+0.0010) 1D
Jun 26, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for L020...
Open
€0.03
High
€0.03
Low
€0.03
Mkt. cap
12.17M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.07
52-wk low
€0.02
No. of employees
28
Open
€0.03
High
€0.03
Low
€0.03
Mkt. cap
12.17M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.07
52-wk low
€0.02
No. of employees
28
News stories
From sources across the web
About Britannia Life Sciences Inc
CEO-
Employees28
Founded2000
Headquarters-
SectorService
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
169.77K
111.87K
65.36K
Cost of goods sold
-
141.47K
73.34K
29.44K
Cost of revenue
-
141.47K
73.34K
29.44K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
375.06K
720.52K
399.98K
Operating expense
-
390.64K
736.35K
415.70K
Total operating expenses
-
532.12K
809.68K
445.14K
Operating income
-
-362.35K
-697.82K
-379.78K
Other non operating income
-
66.34K
-
-
EBT including unusual items
-
-690.95K
-411.28K
12.51M
EBT excluding unusual items
-
-2.37M
-526.26K
-155.36K
Income tax expense
-
-
-
1.67M
Effective tax rate
-
-
-
13.38%
Other operating expenses
-
-
-
-
Net income
-
-690.95K
-411.28K
12.13M
Net profit margin
-
-406.99%
-367.65%
18,555.35%
Earnings per share
-
-
-
-
Interest and investment income
-
-
99.32K
311.64K
Interest expense
-
-8.03K
-6.68K
-5.76K
Net interest expenses
-
-8.03K
92.63K
305.88K
Depreciation and amortization charges
-
15.58K
15.83K
15.72K
EBITDA
-
-346.77K
-681.99K
-364.06K
Gain or loss from assets sale
-
-1.61M
-58.73K
-
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of L020
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more